William F. Elmquist

10.1k citations

145 papers · 7.0k indexed · 1 hit paper · h-index 49

Genetics top 0.5%
- Glioma Diagnosis and Treatment 43
Oncology top 0.5%
- Drug Transport and Resistance Mechanisms 54
Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 10
Pharmaceutical Science top 0.5%
Pediatrics, Perinatology and Child Health top 0.5%
- Pharmacological Effects and Toxicity Studies 26
Pulmonary and Respiratory Medicine
- Brain Metastases and Treatment 18
Infectious Diseases
- HIV/AIDS drug development and treatment 13
Molecular Biology
- DNA Repair Mechanisms 10
- Melanoma and MAPK Pathways 10

Co-authors: Sagar Agarwal Donald W. Miller Rajendar K. Mittapalli Ramola Sane Ronald J. Sawchuk Jann N. Sarkaria John R. Ohlfest Naveed Shaik
Cited by: Genetics Oncology Biomaterials
Journals: Journal of Clinical Oncology (1 paper)Cancer Research (6 papers)Advanced Drug Delivery Reviews (3 papers)
Partner nations: United States New Zealand China

In The Last Decade

William F. Elmquist

140 papers receiving 6.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by William F. Elmquist

Since Specialization

Citations

This map shows the geographic impact of William F. Elmquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William F. Elmquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William F. Elmquist more than expected).

Fields of papers citing papers by William F. Elmquist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William F. Elmquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William F. Elmquist. The network helps show where William F. Elmquist may publish in the future.

Co-authorship network

The 25 scholars most cited alongside William F. Elmquist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William F. Elmquist Line = papers co-authored together William F. Elmquist links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization Science Translational Medicine ·Jiajia Chen,Daniel J. Laverty,Surabhi Talele,Ashwin Bale,Brett L. Carlson,Kendra A. Porath,Katrina K. Bakken,Danielle M. Burgenske,Paul A. Decker,Rachael A. Vaubel,Jeanette E. Eckel‐Passow,Rohit Bhargava,Zhenkun Lou,Petra Hamerlik,Brendan A.C. Harley,William F. Elmquist,Zachary D. Nagel,Shiv K. Gupta,Jann N. Sarkaria	2024	14
2	Modeling the Acute Mucosal Toxicity of Fractionated Radiotherapy Combined with the ATM Inhibitor WSD0628 Molecular Cancer Therapeutics ·D. Garcia,Sneha Rathi,Margaret A. Connors,Michael P. Grams,Rachael A. Vaubel,Katrina K. Bakken,Lauren L. Ott,Brett L. Carlson,Zeng Hu,Paul A. Decker,Jeanette E. Eckel‐Passow,Danielle M. Burgenske,Wei Zhong,Joshua D. Trzasko,Margot Herman,William F. Elmquist,Nicholas B. Remmes,Jann N. Sarkaria	2024	0
3	Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models Clinical Cancer Research ·Sonia Jain,Jessica I. Griffith,Kendra A. Porath,Sneha Rathi,Jiayan Le,Tugce I. Pasa,Paul A. Decker,Shiv K. Gupta,Zeng Hu,Brett L. Carlson,Katrina K. Bakken,Danielle M. Burgenske,Thomas M. Feldsien,Didier R. Lefebvre,Rachael A. Vaubel,Jeanette E. Eckel‐Passow,Edward B. Reilly,William F. Elmquist,Jann N. Sarkaria	2024	9
4	The impact of ATP-binding cassette transporters in the diseased brain: Context matters Cell Reports Medicine ·Chrysiida Baltira,Eleonora Aronica,William F. Elmquist,Oliver Langer,Wolfgang Löscher,Jann N. Sarkaria,Pieter Wesseling,Mark C. de Gooijer,Olaf van Tellingen	2024	16
5	Delivery versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in Glioblastoma Molecular Cancer Therapeutics ·Wenjuan Zhang,Rachael A. Vaubel,Ju-Hee Oh,Ann C. Mladek,Surabhi Talele,Wenqiu Zhang,Katie L. Waller,Danielle M. Burgenske,Jann N. Sarkaria,William F. Elmquist	2023	5
6	The influence of the blood–brain barrier in the treatment of brain tumours Journal of Internal Medicine ·Sneha Rathi,Jessica I. Griffith,Wenjuan Zhang,Wenqiu Zhang,Ju‐Hee Oh,Surabhi Talele,Jann N. Sarkaria,William F. Elmquist	2022	51
7	In Vivo Efficacy of Tesevatinib in EGFR -Amplified Patient-Derived Xenograft Glioblastoma Models May Be Limited by Tissue Binding and Compensatory Signaling Molecular Cancer Therapeutics ·Sani H. Kizilbash,Shiv K. Gupta,Karen E. Parrish,Janice K. Laramy,Minjee Kim,Gautham Gampa,Brett L. Carlson,Katrina K. Bakken,Ann C. Mladek,Mark A. Schroeder,Paul A. Decker,William F. Elmquist,Jann N. Sarkaria	2021	10
8	Methods for intratumoral microdialysis probe targeting and validation in murine brain tumor models Journal of Neuroscience Methods ·Karishma Rajani,Ian Olson,Joshua J. Jacobs,Cécile Riviere-Cazaux,Kirsten Burns,Lucas P. Carlstrom,Mark A. Schroeder,Ju‐Hee Oh,Charles L. Howe,Masum Rahman,Jann N. Sarkaria,William F. Elmquist,Terry C. Burns	2021	4
9	Restricted Delivery of Talazoparib Across the Blood–Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma Molecular Cancer Therapeutics ·Sani H. Kizilbash,Shiv K. Gupta,Kenneth Tou En Chang,Ryo Kawashima,Karen E. Parrish,Brett L. Carlson,Katrina K. Bakken,Ann C. Mladek,Mark A. Schroeder,Paul A. Decker,Gaspar J. Kitange,Yuqiao Shen,Ying Feng,Andrew A. Protter,William F. Elmquist,Jann N. Sarkaria	2017	60
10	ABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B–Driven Brainstem Glioma Model Molecular Cancer Therapeutics ·Rajendar K. Mittapalli,(unknown),Karen E. Parrish,Donna Crabtree,Kyle G. Halvorson,Guo Hu,William F. Elmquist,Oren J. Becher	2016	51
11	Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System Molecular Cancer Therapeutics ·Karen E. Parrish,Ling Cen,J. C. Murray,David Calligaris,Sani H. Kizilbash,Rajendar K. Mittapalli,Brett L. Carlson,Mark A. Schroeder,Julieann Sludden,Alan V. Boddy,Nathalie Y.R. Agar,Nicola J. Curtin,William F. Elmquist,Jann N. Sarkaria	2015	66
12	The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood–Brain Barrier in Glioblastoma Clinical Cancer Research ·Jenny L. Pokorny,David Calligaris,Shiv K. Gupta,Dennis O. Iyekegbe,Dustin Mueller,Katrina K. Bakken,Brett L. Carlson,Mark A. Schroeder,Debra L. Evans,Zhenkun Lou,Paul A. Decker,Jeanette E. Eckel‐Passow,Vincenzo Pucci,Bennett Ma,Stuart D. Shumway,William F. Elmquist,Nathalie Y.R. Agar,Jann N. Sarkaria	2015	71
13	Brain Efflux Index To Investigate the Influence of Active Efflux on Brain Distribution of Pemetrexed and Methotrexate Drug Metabolism and Disposition ·Li Li,Sagar Agarwal,William F. Elmquist	2013	30
14	Active Efflux of Dasatinib from the Brain Limits Efficacy against Murine Glioblastoma: Broad Implications for the Clinical Use of Molecularly Targeted Agents Molecular Cancer Therapeutics ·Sagar Agarwal,Rajendar K. Mittapalli,David M. Zellmer,Jose L. Gallardo,Randy Donelson,Charlie Seiler,Stacy A. Decker,Karen S. SantaCruz,Jenny L. Pokorny,Jann N. Sarkaria,William F. Elmquist,John R. Ohlfest	2012	77
15	Brain Metastases from Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors Clinical Genitourinary Cancer ·Arkadiusz Z. Dudek,Ahmad Raza,Ming Chi,Meghali Singhal,Rajneet K. Oberoi,Rajendar K. Mittapalli,Sagar Agarwal,William F. Elmquist	2012	39
16	Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain Expert Reviews in Molecular Medicine ·Sagar Agarwal,Ramola Sane,Rajneet K. Oberoi,John R. Ohlfest,William F. Elmquist	2011	233
17	Abcg2/Bcrp1 Mediates the Polarized Transport of Antiretroviral Nucleosides Abacavir and Zidovudine Drug Metabolism and Disposition ·Guoyu Pan,Nagdeep Giri,William F. Elmquist	2007	70
18	Review of microdialysis in brain tumors, from concept to application:First Annual Carolyn Frye-Halloran Symposium Neuro-Oncology ·Ramsis Benjamin,Fred H. Hochberg,Elizabeth Fox,Peter M. Bungay,William F. Elmquist,Clinton F. Stewart,James M. Gallo,Jerry M. Collins,Robert P. Pelletier,John de Groot,Robert C. Hickner,Idil Çavuş,Stuart A. Grossman,O. Michael Colvin	2004	40
19	Effect of Probenecid on Fluorescein Transport in the Central Nervous System Using In Vitro and In Vivo Models Pharmaceutical Research ·Haiying Sun,Donald W. Miller,William F. Elmquist	2001	47
20	Transport of Fluorescein in MDCKII-MRP1 Transfected Cells and mrp1-Knockout Mice Biochemical and Biophysical Research Communications ·Haiying Sun,Dennis R. Johnson,Rick A. Finch,Alan C. Sartorelli,Donald W. Miller,William F. Elmquist	2001	54

About William F. Elmquist

William F. Elmquist is a scholar working on Genetics, Oncology and Virology, having authored 145 papers that have together received 7.0k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (54 papers), Glioma Diagnosis and Treatment (43 papers), Pharmacological Effects and Toxicity Studies (26 papers), Brain Metastases and Treatment (18 papers), HIV/AIDS drug development and treatment (13 papers), DNA Repair Mechanisms (10 papers), Melanoma and MAPK Pathways (10 papers) and Nanoparticle-Based Drug Delivery (10 papers). The work is most often cited by research in Genetics (1.5k citations), Oncology (3.3k citations) and Biomaterials (982 citations). William F. Elmquist has collaborated with scholars based in United States, New Zealand and China. Frequent co-authors include Sagar Agarwal, Donald W. Miller, Rajendar K. Mittapalli, Ramola Sane, Ronald J. Sawchuk, Jann N. Sarkaria, John R. Ohlfest, Naveed Shaik, Rajneet K. Oberoi and Alexander V. Kabanov. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Advanced Drug Delivery Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact